Monoclonal antibodies are created by fusing a specific type of immune cell, called a B cell, with a cancer cell to form a hybrid cell called a hybridoma. This hybridoma cell can then produce large quantities of identical antibodies that target a specific antigen. These monoclonal antibodies can be used for various medical purposes, such as diagnosing and treating diseases.
Monoclonal antibodies are made by isolating a specific antibody-producing cell and fusing it with a cancer cell to create a hybrid cell called a hybridoma. This hybridoma can produce large quantities of identical antibodies that target specific proteins on diseased cells, making them a key component in targeted therapies for various diseases.
Monoclonal antibodies are made by fusing a specific type of immune cell called a B cell with a cancer cell to create a hybrid cell called a hybridoma. The hybridoma cell then produces identical antibodies that can target a specific antigen. These antibodies are then harvested and purified for use in various medical treatments and research.
Monospecific Polyclonal antibodies are produced by not just a common germ cell like monoclonal antibodies, but from other products. Monospecific antibodies have affinity for the same antigen.
The process of making monoclonal antibodies involves injecting a specific antigen into a mouse, harvesting the mouse's immune cells, fusing them with cancer cells to create hybridoma cells, screening and selecting the hybridoma cells that produce the desired antibody, and then growing these cells in a lab to produce the monoclonal antibodies in large quantities.
Antibodies attach to specific antigens on the surface of pathogens.
making antibodies
Antiggens
Antibodies attach to specific proteins on the surface of pathogens, called antigens, to help neutralize and eliminate them from the body.
The progeny cells of a B-cell clone are called plasma cells. Plasma cells are responsible for secreting large quantities of antibodies specific to a particular antigen.
Specific response
antibodies